Marvel Biosciences (TSXV:MRVL) EV-to-EBITDA : -2.81 (As of Jun. 21, 2024)

Marvel Biosciences EV-to-EBITDA Chart

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
EV-to-EBITDA	Get a 7-Day Free Trial											-1.91	-1.61	-1.41	-2.09	-3.69

Competitive Comparison of Marvel Biosciences's EV-to-EBITDA

For the Biotechnology subindustry, Marvel Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marvel Biosciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's EV-to-EBITDA falls into.

Marvel Biosciences EV-to-EBITDA Calculation

Marvel Biosciences's EV-to-EBITDA for today is calculated as:

Marvel Biosciences's current Enterprise Value is C$5.66 Mil.
Marvel Biosciences's EBITDA for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences  (TSXV:MRVL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Marvel Biosciences's PE Ratio for today is calculated as:

Marvel Biosciences's share price for today is C$0.11.
Marvel Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Marvel Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences (TSXV:MRVL) Business Description